newsfilter
← Latest News
GlobeNewswire·

Nuwellis Announces Receipt of a Notice of Allowance from the U.S. Patent and Trademark Office for Innovative Dual Lumen Midline Catheter Technology

  • Nuwellis, Inc. (NASDAQ: NUWE) received a Notice of Allowance from the USPTO for a new patent covering its dual lumen midline catheter technology.
  • The patented catheter is designed for use in ultrafiltration therapies & incorporates separate withdrawal & infusion lumens with pressure-balancing features.
  • The device features a segmented reinforcement structure that allows clinicians to customize catheter length at the bedside while maintaining kink resistance & consistent flow.
  • Nuwellis CTO David Lerner stated the patent reflects the company's investment in innovation to improve fluid management solutions for the Aquadex SmartFlow system.
  • Upon issuance, the patented technology is expected to complement Nuwellis' existing portfolio & support expansion of ultrafiltration therapy access in hospital & outpatient settings.
  • Nuwellis is a medical technology company focused on solutions for patients with cardiorenal conditions across acute & chronic care settings.